A carregar...

The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy

Previously we reported that mithramycin represses multiple pathways critical for stem cell signaling and pluripotency in lung cancer cells. This phenomenon coincided with decreased side population fraction and dramatic dose-dependent growth arrest of lung cancer cells in vitro and in vivo. In the pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Am Thorac Soc
Main Authors: Zhang, Mary R., Xi, Sichuan, Shukla, Vivek, Hong, Julie A., Chen, Haobin, Xiong, Yin, Ripley, R. Taylor, Hoang, Chuong D., Schrump, David S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946505/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201707-608MG
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!